Imatinib Mesylate for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors Expressing KIT: A Decade Experience from TaiwanChun‐Nan Yeh, Miin‐Fu Chen, Chun‐Yi Tsai et al.|Translational Oncology|2011Cited by 47
Fas/Fas Ligand Mediates Keratinocyte Death in Sunitinib-Induced Hand-Foot Skin ReactionChun‐Nan Yeh, Wen‐Hung Chung, Shih‐Chi Su et al.|Journal of Investigative Dermatology|2014Cited by 30
Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.Chih-Chieh Hsu, Chun‐Nan Yeh, Chiao‐En Wu et al.|PubMed|2014Cited by 21